Dolotram Capsules 50 mg Capsules.
PDF Leaflet Revision Date: 13 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to severe pain.
Dosage (summary)
Adults: 50 mg initially, then 50-100 mg every 4-6 hours; max 400 mg/day.
Onset of Action / Duration
Onset: 1 hour, Duration: ~6 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAO inhibitors
- CNS depressants
- Carbamazepine
Contraindications
- Children <12 years
- Post-operative use in children <18 years
- Hypersensitivity to tramadol
- Acute intoxication with CNS depressants
Common side effects
- Dizziness
- Nausea
- Constipation
- Somnolence
Counselling Points
- Avoid driving or operating machinery
- Monitor for signs of respiratory depression
- Do not exceed prescribed dose
Serious warnings
- Risk of respiratory depression
- Potential for addiction
- Seizure risk
Important Disclaimer
The Dolotram Capsules 50 mg Capsules. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
